Indeed, studies published in the early years of the HIV-1 pandemic reported that patients with HIV-1 dementia presented a higher concentration of β2m in their cerebrospinal fluid (45) and that β2m levels were raised in the serum of AIDS-related complex patients (44) and during HIV-1 infection progression (43, 46). This evidence concerns the gene B2M and HIV-1 infection.